title: Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group study.
authors.affiliation: University of Oklahoma Health Center, Oklahoma City.
authors.forename: J P
authors.initials: JP
authors.lastname: Kuebler
authors.forename: B
authors.initials: B
authors.lastname: Metch
authors.forename: D E
authors.initials: DE
authors.lastname: Schuller
authors.forename: M
authors.initials: M
authors.lastname: Keppen
authors.forename: H E
authors.initials: HE
authors.lastname: Hynes
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001374:Azacitidine / Q000009:adverse effects / Q000627:therapeutic use* / Q000031:analogs & derivatives; D004341:Drug Evaluation; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D000970:Antineoplastic Agents; C022121:fazarabine; D001374:Azacitidine